- JP-listed companies
- CanBas Co.,Ltd.
- Balance sheet
CanBas Co.,Ltd. (4575) Balance sheet
Market cap
¥15.6B
P/E ratio
Canvas is a biotech company that discovers and develops cancer drugs using its proprietary platform, from early research through clinical trials.
| 2013/06 | 2014/06 | 2015/06 | 2016/06 | 2017/06 | 2018/06 | 2019/06 | 2020/06 | 2021/06 | 2022/06 | 2023/06 | 2024/06 | 2025/06 | 2026/06 | |
| Cash and cash equivalents | - | 323 | 885 | 815 | 889 | 466 | 764 | 1,112 | 1,155 | 738 | 1,618 | 1,888 | 2,828 | 1,445 |
| Total current assets | - | 343 | 953 | 923 | 974 | 546 | 844 | 1,232 | 1,264 | 759 | 2,068 | 2,308 | 2,957 | 1,679 |
| Property, plant and equipment, net | - | 31 | 23 | 23 | - | - | - | - | - | - | - | - | - | - |
| Total non-current assets | - | 54 | 45 | 44 | 20 | 32 | 31 | 31 | 32 | 32 | 18 | 124 | 94 | 98 |
| Total assets | - | 397 | 998 | 967 | 993 | 578 | 875 | 1,263 | 1,296 | 791 | 2,086 | 2,433 | 3,051 | 1,777 |
| Total current liabilities | - | 26 | 33 | 38 | 66 | 156 | 219 | 276 | 108 | 173 | 154 | 92 | 107 | 135 |
| Total non-current liabilities | - | 37 | - | - | - | - | - | 750 | 750 | 367 | - | - | - | - |
| Total liabilities | - | 63 | 33 | 38 | 66 | 156 | 219 | 1,026 | 858 | 540 | 154 | 92 | 107 | 135 |
| Retained earnings | - | -6,350 | -6,617 | -7,032 | -7,452 | -7,984 | -8,440 | -9,013 | -9,544 | -10,399 | -11,643 | -12,853 | -14,011 | -15,320 |
| Stockholders' equity | 635 | 335 | 965 | 929 | 927 | 422 | 656 | 237 | 438 | 251 | 1,932 | 2,341 | 2,944 | 1,642 |